Free shipping on all orders over $ 500

FAAH

Cat.No.  Name Information
M44945 N-Benzyllinolenamide N-​Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM.
M18241 N-Benzylpalmitamide N-Benzylpalmitamide is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH).
M9271 BIA 10-2474 BIA 10-2474 is a long-acting reversible inhibitor of fatty acid amide hydrolase (FAAH).
M8950 JNJ-42165279 JNJ-42165279 is a potent and selective FAAH inhibitor with IC50s of 70 ± 8 nM and 313 ± 28 nM for hFAAH and rFAAH, respectively.
M7115 PF 04457845 PF 04457845 is a potent and selective irreversible FAAH inhibitor.
M6169 FAAH-IN-2 FAAH-IN-2 is a potent FAAH (fatty acid amide hydrolase) inhibitor.
M4693 Biochanin-A Biochanin A is A naturally occurring fatty acid amide hydrolase (FAAH) inhibitor that inhibits FAAH in mice, rats and humans with FAAH IC50 of 1.8, 1.4 and 2.4 μM, respectively.
M3525 PF-3845 PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2.
M3404 URB597 URB597 is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets.
M2783 JNJ-1661010 JNJ-1661010 is a potent and selective FAAH inhibitor with IC50 of 10 nM (rat) and 12 nM (human), exhibits >100-fold selectivity for FAAH-1 when compared to FAAH-2.
M44941 N-(3-Methoxybenzyl)palmitamide N-(3-Methoxybenzyl)Palmitamide is a promising inhibitor of FAAH for the treatment of pain, inflammation and CNS degenerative disorders.
M42393 VU534 VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.In addition, VU534 can dependently enhance Efferocytosis in macrophages. VU534 can be used in studies of cardiometabolic diseases.
M27945 MK-4409  MK-4409 is a potent oxazole FAAH inhibitor and can be used for the research of inflammatory and neuropathic pain.
M14426 URB-597 URB-597 (KDS-4103) is an orally bioavailable and selective FAAH inhibitor.
M14425 LY2183240 LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM.




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.